Domov › Mikrocitni rak pljuč › Missouri
Klinične študije za Mikrocitni rak pljuč v Missouri
17 študij za Mikrocitni rak pljuč išče udeležence na lokacijah v Missouri.
Mesta v Missouri
Uradno besedilo študije (angleško)
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Missouri Cancer Associates /ID# 278299, Columbia
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07155174DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- HCA MidAmerica Division, Inc., Kansas City
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07472517A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Missouri Cancer Associates, Columbia
- Mercy South, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07218146Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06712355Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- WA Uni School Of Med, St Louis
Vključevanje udeležencevFaza 1/2
Starost 18–100 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT06726148A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- Washington University Medicine, St Louis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07488923Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
- Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT07155200A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Mercy Clinic Oncology and Hematology Sindelar Cancer Center, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06203210DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
- Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07545954A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- MidAmerica Cancer Care, Kansas City
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT06131840A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Washington University School of Medicine (Siteman Cancer Center), St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 15. jul. 2026 · NCT05652686A Study of LY4175408 in Participants With Advanced Cancer
- Washington University, St Louis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07046923Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
- Siteman Cancer Center, Washington University, St Louis
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 8. maj 2026 · NCT05363280Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit
- in še 2
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. mar. 2026 · NCT06769126Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Washington University, St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 18. feb. 2026 · NCT07030257JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
- Washington University, St Louis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 9. jan. 2026 · NCT054904727T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
- University of Missouri, Columbia
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 2. dec. 2025 · NCT07175077Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.